Decoding 4 Analyst Evaluations For Altimmune
Decoding 4 Analyst Evaluations For Altimmune
解讀altimmune的4個分析師評價
The perception of Altimmune...Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Altimmune (NASDAQ:ALT) in the last three months.
在過去三個月裏，有4位分析師從看多到看空，對Altimmune（納斯達克：ALT）進行了評級。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
總結他們最近的評估，下表展示了過去30天內不斷變化的情緒，並將其與之前的幾個月進行了比較。
In the assessment of 12-month price targets, analysts unveil insights for Altimmune, presenting an average target of $19.25, a high estimate of $25.00, and a low estimate of $12.00. Consistency is reflected as the current average remains at the same level as the previous average price target.
資產回報率（roa）：altimmune的roa低於行業標準，說明在有效利用資產方面存在困難。roa爲-13.62%，該公司可能在從資產中獲得令人滿意的回報方面面臨挑戰。
Breaking Down Analyst Ratings: A Detailed Examination
分析師評級分析：詳細分析
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間